$CADL

$7.79 -$0.24 (2.99%) Close

$CADL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 76.5M shares outstanding

Who owns CADL?

By type of holder

Institutions 65.6% Insiders 8.8% Everyone else 25.6%

Concentration Top 10 holders own 60.5%

FMR LLC 14.4% · RTW Investments, LP 8.4%

Institutional ownership

65.6%

+8.8 pts vs last qtr

Institutional holders

136

+22 vs last qtr

Net shares bought

+6.7M

by institutions in Q2 2026

New / sold out

39 / 17

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

State Street Corp +2.7M
BlackRock, Inc. +1.9M

Biggest sellers in Q2 2026

Vestal Point Capital, LP SOLD OUT −1.1M
Heights Capital Management, Inc SOLD OUT −775.0K

Who is planning to sell?

Notices of proposed sale, last 12 months

$3.79M

4 notices from 4 people

Shares covered

317.7K

0.42% of the company

Arranged in advance

100%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Paul Peter Tak Director 10b5-1 $3.41M
Francesca Barone Officer 10b5-1 $230K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2021–FY2025

+180.6%

+29.43% a year

Each share's claim on the business

−64.4%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $17.5M

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years30% 1–3 years42% Under 1 year28%

Quarterly turnover

15.6%

of institutional shares changed hands

Top 10 managers, median time held

1.8 years

Super Investors

Investment managers reporting CADL on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
F FMR LLC	11.0M	14.36%	+3.5K (+0.0%)	2024	0.0%
Shares held by quarter Peak holding11.0M (Q2'26) Change over 8 quarters+11.0M Share of the company14.360% FMR LLC's full portfolio →
RI RTW Investments, LP	6.4M	8.39%	Unchanged	Q1 '26	0.6%
Shares held by quarter Peak holding6.4M (Q1'26) Change over 8 quarters+6.4M Share of the company8.390% RTW Investments, LP's full portfolio →

FMR LLC

11.0M

% of company

14.36%

Change vs last qtr

+3.5K (+0.0%)

Held since

2024

RTW Investments, LP

6.4M

% of company

8.39%

Change vs last qtr

Unchanged

Held since

Q1 '26

28 more super investors behind a free account

See every manager holding Candel Therapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting CADL on Form N-PORT; together they hold 27.7% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SB Select Biotechnology Portfolio Fidelity Select Portfolios	$63.6M	4.9M	6.36%	1.01%	August 31, 2026
FG Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust	$29.9M	2.3M	2.99%	0.03%	August 31, 2026

Select Biotechnology Portfolio

Fidelity Select Portfolios

Position value

$63.6M

% of company

6.36%

% of the fund

1.01%

As of

August 31, 2026

Fidelity Growth Company Fund

Fidelity Mt. Vernon Street Trust

Position value

$29.9M

% of company

2.99%

% of the fund

0.03%

As of

August 31, 2026

23 more funds behind a free account

See every fund holding Candel Therapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
PB Paul B Manning 5%+ holder 13D · 7.9%	5.8M	7.57%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company7.570% Disclosed stake13D · 7.9% View the 13D/G filing →
MC Martell Christopher Insider	546.9K	0.71%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.710% Martell Christopher's insider activity →

Paul B Manning

5%+ holder13D · 7.9%

5.8M

% of company

7.57%

Change vs last qtr

—

Held since

—

Martell Christopher

Insider

546.9K

% of company

0.71%

Change vs last qtr

—

Held since

—

8 more holders behind a free account

See every insider and 5%+ holder of Candel Therapeutics Inc.

Comments